Moderna stock surges as melanoma vaccine trial shows "landmark moment"
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
Watch CBS News
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
A vaccine and cancer drug dramatically improved survival rates for those with severe melanomas, results after three years showed.
Drugmaker Merck, the company behind a COVID-19 pill that was being studied in South Florida, has filed an application with the U.S. Food and Drug Administration asking for emergency for authorization of its use.
A new breakthrough pill for treating people with Covid that was tested in South Florida may be available in a couple of months.
An iconic image of Miami's history has been saved.
A grieving mother is warning others about a popular medication, taken by millions, that can cause devastating and long term side effects.